PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Corporate Development, Department of Regulatory Affairs, Taiwan Liposome Company, Ltd., Taipei, Taiwan.\', \'Division of Product Development, Department of Pharmacokinetics, Taiwan Liposome Company, Ltd., Taipei, Taiwan.\', \'Division of Respiratory Therapy, Department of Integrated Diagnostics and Therapeutics, National Taiwan University Hospital, Taipei, Taiwan.\', \'Division of Product Development, Department of Medical Science, Taiwan Liposome Company, Ltd., Taipei, Taiwan.\', \'Division of Product Development, Taiwan Liposome Company, Ltd., Taipei, Taiwan.\', \'Division of Infectious disease, Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/cts.12923
?:doi
?:hasPublicationType
?:journal
  • Clinical and translational science
is ?:pmid of
?:pmid
?:pmid
  • 33135382
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.669
?:rankingScore_hIndex
  • 31
is ?:relation_isRelatedTo_publication of
?:title
  • A Strategy to Treat COVID-19 Disease With Targeted Delivery of Inhalable Liposomal Hydroxychloroquine: A Preclinical Pharmacokinetic Study.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33135382>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33135382>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all